InMed Pharmaceuticals's banner

InMed Pharmaceuticals

@inmedpharma • 2,048 subscribers

Developing small molecule compounds for the treatment of #Alzheimers, Age-related #Macular Degeneration #AMD, & #EB. Our subsidiary @BayMedica NASDAQ: $INM

Shorts

InMed's INM-901 demonstrates a multi-factorial approach to potentially treat Alzheimer's disease, including neuroprotective effects, an ability to extend the length of neurites, which is important for brain cell-to-cell communication, as well as a reduction in neuroinflammation.

InMed's INM-901 demonstrates a multi-factorial approach to potentially treat Alzheimer's disease, including neuroprotective effects, an ability to extend the length of neurites, which is important for brain cell-to-cell communication, as well as a reduction in neuroinflammation.

2,676,765 views